Skip to content
OpenCapital
Get started

Sabra Healthcare SBRA Net additions (releases) charged to costs and expenses

Net additions (releases) charged to costs and expenses at other companies

Omega Healthcare Investors logo
Omega Healthcare InvestorsOHI
——

Other financials

Income statement

See full
Revenue$221.8M+20.8%
Net income$40.9M+1.4%
EPS (diluted)$0.16-5.9%

Balance sheet

See full
Cash & equivalents$116.5M+414%
Total debt$7.3M-9.6%
Total equity$2.8B+3.1%
Total assets$5.6B+6.8%

Cash flow

See full
Operating cash flow$98.4M+22.5%

Valuation

See full
Market cap$4.57B+16.7%

Profitability

See full
Net margin19.2%-0.3pp

Returns & leverage

See full
Return on equity5.7%+0.5pp
Debt / equity0×0.0×

Where this comes from

Reported directly by Sabra Healthcare in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Sabra Healthcare’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sabra Healthcare's net additions (releases) charged to costs and expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sabra Healthcare's net additions (releases) charged to costs and expenses?
Sabra Healthcare (SBRA) reported net additions (releases) charged to costs and expenses of -$213K in Q1 2026.
How has Sabra Healthcare's net additions (releases) charged to costs and expenses changed year-over-year?
Sabra Healthcare's net additions (releases) charged to costs and expenses decreased by 23.1% year-over-year, from -$173K to -$213K.
What is the long-term trend for Sabra Healthcare's net additions (releases) charged to costs and expenses?
Over 3 years (2021 to 2025), Sabra Healthcare's net additions (releases) charged to costs and expenses has grown at a -35.7% compound annual growth rate (CAGR), from $3.94M to -$1.05M.